23
Views
11
CrossRef citations to date
0
Altmetric
Articles

Beta-Lactamase Patterns and Beta-Lactam/Clavulanic Acid Resistance in Escherichia coli Isolated from Fecal Samples from Healthy Volunteers

Pages 208-215 | Published online: 18 Jul 2013

REFERENCES

  • Shanahan PMA, Thomson CJ, Amyes SGB. The global impact of antibiotic resistant bacteria: their sources and reser-voirs. Rev Med Microbiol 1994; 5: 174–82.
  • Levy SB, Marshall B, Schluderberg S, Rowse D, Davis J. High frequency of antimicrobial resistance in human faecal flora. Antimicrob Agents Chemother 1988; 32: 1801–6.
  • Meares EM Jr. Nosocomial infectios of urinary tract, changing pathogens changing patterns. Urology 1985; 26 (1 Suppl): 2–4.
  • Shanahan PMA, Thomson CJ, Amyes SGB. b-lactam resistance in aerobic commensal faecal flora. Int J Antimicrob Agents 1994; 3: 259–66.
  • Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 662–90.
  • Cooksey R, Swenson J, Clark N, Gay E, Thornsberry C. Patterns and mechanism of β-lactam resistance among isolates of Escherichia coli from hospitals in the United States. Antimicrob Agents Chemother 1990; 34: 739–45.
  • Roy C, Foz A, Segura C, Tirado M, Fuster C, Reig R. Plasmid determined 13-lactamases identified in a group of 204 ampicillin resistant Enterobacteriaceae. J Antimicrob Chemother 1983; 12: 507–10.
  • Liu PYF, Cur D, Hall LMC, Livermore DM. Survey of the prevalence of β-lactamases amogst 1000 Gram-negative bacilli isolated consecutively at the Royal London Hospital. J Antimicrob Chemother 1992; 30: 429–47.
  • O'Shaughnessy EM, Fahle GA, Witebsky FG. Correlation of in vitro test results for amoxicillin-clavulanate and ampicillin-sulbactam tested against Escherichia coli. J Clin Microbiol 1997; 35: 1902–3.
  • Henquell C, Chanal C, Sirot D, Labia R, Sirot J. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM 13-lactamases from clinicalisolates of Escherichia coli. Antimicrob Agents Chemother 1995; 39: 427–30.
  • Stapleton P, Wu PJ, King A, Shannon K, French G, Phillips I. Incidence and mechanisms of resistance tothe com-bination of amoxicillin and clavulanic acid in Escherichia coli. Antimicrob Agents Chemother 1995; 39: 2478–83.
  • Thomson CJ, Amyes SGB. TRC-1: emergence of a clavulanic acid-resistant TEM β-lactamase in a clinical strain. FEMS Microbiol Lett 1992; 91: 113–8.
  • Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr WC, eds. Color atlas and textbook of diagnostic microbiology. 5th ed. New York: Lippincott, 1997: 196–200.
  • National Committee for Clinical Laboratory Standarts. Methods for dilution antimicrobial susceptibility tests for bacte-ria that grow aerobically. Approved standart M7-A4. National Committee for Clinical Laboratory Standarts, Villanova, PA. 1997.
  • National Committee for Clinical Laboratory Standarts. Performance standarts for antimicrobial disk susceptibility tests. Approved standart M2-A6. National Committee for Clinical Laboratory Standarts, Wayne, PA, 1997.
  • Jarlier V, Nicholas MH, Fournier G, Phillippon A. Extended-broad spectrum beta-lactamases conferring transfer-able resistance to newer beta-lactam agents in Enterobacter-iaceae; hospital prevalance and susceptibility patterns. Rev Infect Dis 1988; 10: 867–78.
  • Bachmann BJ. Pedigrees of some mutant strains of Escherichia coli. Bacteriol Rev 1972; 36: 525–57.
  • Kado CI, Liu ST. Rapid procedure for detection and isolation of large and small plasmids. J Bacteriol 1981; 145: 1365–73.
  • Nandivada LS, Amyes SGB. Plasmid-mediated b-lactam resistance in pathogenic Gram-negative bacteria isolated in South India. J Antimicrob Chemother 1990; 26: 279–90.
  • Matthew NI, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for the detection and iden-tification of beta-lactamases. J Gen Microbiol 1975; 88: 169–178
  • Waddell WJ, Hill C. A simple ultraviolet spectrophoto-metric method for the determination of protein. J Lab Clin Med 1956; 48: 311–3.
  • Payne DJ, Marriott MS, Amyes SGB. TEM-El: a novel beta-lactamase conferring resistance to ceftazidime. FEMS Microbiol Lett 1989; 50: 97–100.
  • Moorhouse EC. Transferable drug resistance in enter-°bacteria isolated from urban infants. Br Med J 1969; 2: 405–7.
  • Linton KB, Lee PA, Richmond MH et al. Antibiotic resistance and transmissible R-factors in the intestinal coliform flora of healthy adults and children in an urban and a rural community. J Hyg 1972; 70: 99–104.
  • Bonten M, Stobberingh E, Phillips J, Houben A. High prevalance of antibiotic resistant Escherichia coli in faecal samples of students in the south-east of The Netherlands. J Antimicrob Chemother 1990; 26: 585–92.
  • Lester SC, del Pilar PM, Wang F, Perez SI, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela and in Qin Pu, China. N Engl J Med 1990; 323: 285–9.
  • Amyes SGB, Tait S, Thomson CJ et al. The incidence of antibiotic resistance in aerobic faecal flora in South India. J Antimicrob Chemother 1992; 29: 415–25.
  • Shanahan PMA, Wylie BA, Adrian PV, Koornhof HJ, Thomson CJ, Amyes SGB. The prevalance of antimicrobial resistance in human faecal flora in South Africa. Epidemiol Infect 1993; 111: 221–8.
  • Reguera JA, Baquero F, Pêrez-Diaz JC, Martinez JL. Factors determining resistance to β-lactam combined with 13-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother 1991; 27: 569–75.
  • Wu PJ, Shannon K, Phillips I. Effect of hyperproduc-tion of TEM-1 β-lactamase on in vitro susceptibility of Escherichia coli to β-lactam antibiotics. Antimicrob Agents Chemother 1994; 38: 494–8.
  • Thomson K, Weber DA, Sanders CC, Sanders WEJr. β-lactamase production in members of the family Enterobacteriaceae and resistance to β-lactam-enzyme inhibitor combinations. Antimicrob Agents Chemother 1990; 34: 622–7.
  • Thou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L. Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 β-lactamase conferring resis-tance to β-lactamase inhibitors. Antimicrob Agents Chemother 1994; 38: 1085–9.
  • Blasquez J, Baquero MR, Canton R, Abs I, Baquero F. Characterization of a new TEM-type β-lactamase resistant to clavulnate, sulbactam and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother 1993; 37: 2059–63.
  • Oliver A, Pêrez-Vazquez M, Martinez-Ferrer M, Baquero F, De Rafael L, Canton R. Ampicillin-sulbactam and amoxycillin-clavulanate susceptibility testing of Escherichia coli isolates with different β-lactam resistance phenotypes. Antimicrob Agents Chemother 1999; 43: 862–7.
  • Vanjak D, Muller-Serieys C, Picard B, Bergogne-Berezin E, Lambert-Zechovsky N. Activity of beta-lactamase inhibitor combinations on Escerichia coli isolates exhibiting various patterns of resistance to beta-lactam agents. Eur J Clin Microbiol Infect Dis 1995; 14: 972–8.
  • Bush K, Jacoby GA, Mederios AA. A functional classifi-cation scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211–33.
  • Normark S, Lindquist S, Lindberg F. Chromosomal beta-lactam resistance in enterobacteria. Scand J Infect Dis 1986; 49: 38–45.
  • Sawai T, Yamaguchi A, Hiruma R. Effect of interaction between outer membrane permeability and beta-lactamase production on resistance to beta-lactam agents in Gram-nega-tive bacteria. Rev Infect Dis 1988; 10: 761–4.
  • Stapleton PD, Shannon K, French GL. Carbapenem resistance in Escherichia coli associated with plasmid deter-mined CMY-4 β-lactamase production and loss of an outer membrane protein. Antimicrob Agents Chemother 1999; 43: 1206–10.
  • Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae. Clin Infect Dis 1998; 27 (suppl1): S100-6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.